Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Farlutal
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Farlutal 100 tablets
0803020H0BCAAAC
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 250 tablets
0803020H0BCABAE
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 suspension for injection 2.5ml vials
0803020H0BCADAB
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 tablets
0803020H0BCACAG
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.